Janus Henderson Group PLC Orasure Technologies Inc Transaction History

Janus Henderson Group PLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$4.2 - $6.18 $1,528 - $2,249	-364 Reduced 1.2%	30,009 $127,000
Q1 2024 May 15, 2024	BUY	$6.08 - $8.28 $24 - $33	4 Added 0.01%	30,373 $186,000
Q4 2023 Feb 14, 2024	SELL	$5.13 - $8.35 $282 - $459	-55 Reduced 0.18%	30,369 $249,000
Q3 2023 Nov 14, 2023	BUY	$4.4 - $6.91 $13 - $20	3 Added 0.01%	30,424 $180,000
Q2 2023 Aug 14, 2023	SELL	$4.88 - $7.39 $185 - $280	-38 Reduced 0.12%	30,421 $152,000
Q1 2023 May 15, 2023	BUY	$4.66 - $6.52 $74,094 - $103,668	15,900 Added 109.21%	30,459 $184,000
Q3 2022 Nov 14, 2022	BUY	$2.72 - $4.61 $19 - $32	7 Added 0.05%	14,559 $55,000
Q2 2022 Aug 15, 2022	SELL	$2.71 - $7.12 $21 - $56	-8 Reduced 0.05%	14,552 $39,000
Q1 2022 May 16, 2022	SELL	$6.62 - $9.33 $6 - $9	-1 Reduced 0.01%	14,560 $99,000
Q4 2021 Feb 14, 2022	BUY	$8.3 - $11.29 $120,856 - $164,393	14,561 New	14,561 $127,000

202

65.5M

2.2K

5.1K

Ticker OSUR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 72,619,104
Market Cap $277M
Description
OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, and sells oral fluid diagnostic products and specimen collection devices in the United States, Europe, and internationally. It operates in two segments, Diagnostics and Molecular Solutions. The company's principal products include InteliSwab COVID-19 rap...

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

Stay updated on Janus Henderson Group PLC with notifications on news.